PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 60 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,005,568 | +35.3% | 163,507 | +190.4% | 0.01% | +50.0% |
Q4 2022 | $743,292 | +852.9% | 56,310 | +114.1% | 0.00% | – |
Q3 2022 | $78,000 | -85.1% | 26,302 | -59.3% | 0.00% | -100.0% |
Q4 2021 | $524,000 | -50.9% | 64,663 | -9.7% | 0.01% | -61.5% |
Q3 2021 | $1,067,000 | +240.9% | 71,618 | +187.0% | 0.01% | +225.0% |
Q2 2021 | $313,000 | – | 24,953 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
tru Independence LLC | 500 | $0 | 0.00% |
Renaissance Technologies | 120,269 | $319,000 | 0.00% |
D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |